Advertisement

Topics

USA reports ongoing IP challenges as China extends drug exclusivity period

11:42 EDT 17 May 2018 | thePharmaLetter

For the 14th consecutive year, the USTR has put China on a ‘priority watch list' on its annual analysis…

Original Article: USA reports ongoing IP challenges as China extends drug exclusivity period

NEXT ARTICLE

More From BioPortfolio on "USA reports ongoing IP challenges as China extends drug exclusivity period"

Advertisement
Quick Search
Advertisement
Advertisement